Decitabine—Bedside to bench - ScienceDirect
Mechanism of action of the reviewed HMA and IDH inhibitors. a... | Download Scientific Diagram
Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia
Figure Structure and trapping mechanism of decitabine. A) The chemical... | Download Scientific Diagram
Hypomethylating agents are effective in myelodysplastic syndrome | Cancer Biology
Figure 2 from Targeting DNA Methylation | Semantic Scholar
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers | Clinical Epigenetics | Full Text
Immunotherapy of Myelodysplastic Syndrome: You Can Run, but You Can't Hide | Clinical Cancer Research
PDF) An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes
Clinical update on hypomethylating agents | SpringerLink
JCI - Clinical development of demethylating agents in hematology
Decitabine - an overview | ScienceDirect Topics
Targeting DNA Methylation | Clinical Cancer Research
The role of hypomethylating agents in the treatment of elderly patients with AML
JCM | Free Full-Text | Proteomic Studies for the Investigation of γ-Globin Induction by Decitabine in Human Primary Erythroid Progenitor Cultures | HTML
Intracellular methabolic pathways of azacitidine and decitabine. After... | Download Scientific Diagram
Decitabine | C8H12N4O4 - PubChem
A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
Azacitidine | Nature Reviews Drug Discovery
Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors | Epigenomics
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers | Clinical Epigenetics | Full Text
Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors | Epigenomics
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine - Stresemann - 2008 - International Journal of Cancer - Wiley Online Library
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network | Leukemia
Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
